课题基金 / 基金详情

项目摘要

项目成果

STANLEY R HOFFMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One percent of newborn humans have some congenital heart defect, usually in the septation of the heart. Little is known, about the molecular bases for the cellular processes that drive the well-characterized series of morphological changes in heart development. Specific molecules involved in cell-substrate adhesion (SAMs) and cell-cell adhesion (CAMs) regulate morphogenesis in other systems and are correlated with developmentally- important primary processes such as cell migration, cell division, programmed cell death, cytodifferentiation. In the first two years of this project, we identified two SAMs, cytotactin and cytotactin-binding proteoglycan (CTB Proteoglycan), and a CAM, N-CAM, whose distributions in the heart, functions, and structures suggest that they may be involved in heart development. Our long-term goal is to determine the mechanisms through which this control is exerted by these molecules and other cell adhesion molecules. Our specific aims for this project period are to use biochemical, cell biological, molecular biological, and immunohistochemical techniques to 1) analyze the structure of CTB proteoglycan and the relationship of its structure and its function, 2) identify and characterize cell surface receptors and extracellular matrix proteins that interact with CTB proteoglycan, 3) determine the effects of cytotactin and CTB proteoglycan on the migration, proliferation, and differentiation of endocardial cushion cells which form the septation of the heart and 4) determine distribution and functions of a variant form of N-CAM found only in heart and skeletal muscle. These studies will begin to elucidate the mechanisms through which cell adhesion molecules can alter patterns of cell migration, cell division, and differentiation and thereby affect heart development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Therapeutics for Heart Failure: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development
  • 批准号:
    10599654
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2023
  • 负责人:
    STANLEY R HOFFMAN
  • 依托单位:
Development of Modified Caveolin-1 Scaffolding Domain Peptides with Improved Pharmacological Properties as Therapeutic Agents for Scleroderma Skin Disease
  • 批准号:
    10544238
  • 项目类别:
  • 资助金额:
    $25.96万
  • 财政年份:
    2022
  • 负责人:
    STANLEY R HOFFMAN
  • 依托单位:
Novel Therapeutics for Interstitial Lung Disease: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development
  • 批准号:
    10544228
  • 项目类别:
  • 资助金额:
    $29.99万
  • 财政年份:
    2022
  • 负责人:
    STANLEY R HOFFMAN
  • 依托单位:
Curcumin Treatment of Lung Fibrosis: Improved Delivery and Target Cells
国内基金
海外基金
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造 血干细胞生成中的作用及机制研究
  • 批准号:
    TGY24H080011
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    李鸿鹄
  • 依托单位: